Background: Impaired right ventricular systolic (RVS) function is of great prognostic relevance in patients (pts) with mitral valve disease. MitraClipÒ implantation (MCI) has shown to significantly reduce mitral regurgitation (MR) of primary and secondary etiology. The aim of this subgroup analysis was to assess which left ventricular basic echocardiographic parameters before the procedure predict the normalization of initially reduced RVS function Methods: Out of a total population of n¼323 pts with severe MR who underwent MCI, we retrospectively included 121 consecutive pts for whom the transthoracic echocardiography data were available (cases 155-276). Inclusion criterion for further analysis was an impaired RVS function (TAPSE < 18 mm) before MCI. MR grade and TAPSE were evaluated at 6 weeks and at 6 months after implantation. Improvement of the RVS function was defined by TAPSE > 18 mm. MR etiology as well as systolic (LVEF) and diastolic (E/E' Ratio) function of the left ventricle were tested as predictors of improvement of RVS function (WilcoxonTest). Results: 39 pts (12 female) with a mean age of 74 AE 11 years were found to have a reduced TAPSE. 6 weeks after the treatment, TAPSE normalized in 12 (31 %) pts (Group 1), whereas in 27 (69 %) pts it did not (Group 2). Pts in Group 1 had significantly more frequent a MR of primary etiology and a significantly higher LVEF (Table 1) together with a significantly lower E/E' Ratio (Table 1 ). There was no difference regarding MR reduction between the two groups. Results at 6 months follow up (31 % of pts) did not differ from 6 weeks data. Conclusions: Improvement of the right ventricular systolic function after MitraClipÒ implantation is much more probable in patients with primary mitral regurgitation or without a severe left ventricular dysfunction.
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Background: Impaired right ventricular function (RVF) is of great prognostic relevance in patients (pts) with mitral valve disease. MitraClipÒ implantation (MCI) has shown to significantly reduce mitral regurgitation (MR). A possible side effect though is iatrogenic mitral valve stenosis (IMVS). This preliminary study aims to verify the impact of IMVS on RVF.
Methods: Out of a total population of 323 pts with severe mitral regurgitation (MR) who underwent MCI, we retrospectively enrolled those pts for whom right heart transthoracic echocardiography and sufficient follow-up data were available. The RVF function was assessed by TAPSE, which was defined as pathological when < 18 mm. The IMVS was assessed a few days after MCI with cw-doppler based gradient measurement (ΔP mean discharge).
Results: In 55 pts (22 female; age: 74 +/-11 years) it was possible to measure: TAPSE and MR, before and 6 weeks (6W) after MCI and ΔP mean discharge.
Comparing the initial TAPSE to that measured after 6W, we have found 4 Groups of pts with different patterns of TAPSE development: Group 1, that normalizes its initially impaired TAPSE; Group 2, that decreases its initially normal TAPSE; Group 3 with permanently normal TAPSE and Group 4 with permanently pathological TAPSE values. Between the 4 groups there was no significant difference in MR reduction and in ΔP mean discharge (Table 1) . Although not statistically significant Group 2 was found to have a higher ΔP mean discharge than all other groups.
Conclusions: This preliminary study shows that ΔP mean discharge does not predict right ventricular systolic function after MCI. Although there seems to be a tendency that pts, with an iatrogenic mitral stenosis, of more than mild severity, worsen their initially normal TAPSE after the procedure. www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM-5:30 PM 
